Padcev 30mg Injection

Padcev 30mg Injection contains the active substance enfortumab vedotin. It is an antineoplastic drug belonging to the class of antibody-drug conjugates (ADCs). Padcev 30mg Injection is used to treat adults with locally advanced or metastatic urothelial cancer who have previously received a PD-1 or PD-L1 inhibitor and platinum-containing chemotherapy. Padcev Injection works by targeting a protein called Nectin-4, which is highly expressed in urothelial cancer cells. The drug delivers a cytotoxic agent known as monomethyl auristatin E (MMAE) directly to the cancer cells. Once inside the cells, MMAE disrupts the microtubule network, leading to cell cycle arrest and cell death. This targeted mechanism helps to destroy cancer cells whilst minimising damage to healthy tissues. Do not give Padcev 30mg Injection to children or adolescents under the age of 18. Do not use Padcev 30mg Injection if you are allergic to enfortumab vedotin or any other ingredients of this medicine. Before starting treatment, inform your doctor if you have a history of kidney problems, heart conditions, eye disorders or if you have experienced lung inflammation. Report any symptoms such as difficulty breathing with cough or fever, severe skin peeling, persistent fever, easy bruising or bleeding, unusual tiredness, pale skin, or signs of infection to your healthcare provider promptly. Padcev 30mg price varies based on the seller and location.

Padcev 30mg Injection is used in the treatment of the following: Locally advanced or metastatic urothelial cancer in adult patients who have previously received a PD-1 or PD-L1 inhibitor and platinum-containing chemotherapy.

Padcev 30mg Injection works by targeting Nectin-4 on cancer cells and delivering monomethyl auristatin E (MMAE), a cytotoxic agent. Once inside the cancer cells, MMAE interferes with the microtubule network, causing cell cycle arrest and triggering cell death (apoptosis). This targeted mechanism enables the selective destruction of cancer cells while minimizing harm to healthy tissues.

Padcev side effects are unwanted symptoms caused by medicines. Although all drugs can cause side effects, not everyone experiences them. Common side effects of Padcev 30mg Injection are Fatigue Nausea Decreased appetite Diarrhea Rash Hair loss (alopecia) Altered taste (dysgeusia) Dry eyes Serious side effects of Padcev 30mg Injection are: Severe Peripheral Neuropathy: May require padcev enfortumab vedotin dosage adjustment or discontinuation of treatment. Serious Skin Reactions: Including conditions like Stevens-Johnson syndrome and toxic epidermal necrolysis; treatment should be stopped immediately if these occur. Hyperglycemia: Can result in ketoacidosis or hyperosmolar hyperglycemic state; requires careful monitoring and management.